Jubilant Pharmova Limited (JUBLPHARMA.NS) NSE

1,069.10

+28.5(+2.74%)

Updated at January 14 02:55PM

Currency In INR

Valuation

Market Cap145.64B
Enterprise Value162.07B
P/E Ratio35.39
PEG Ratio9.18
Price/Sales Ratio2.22
Price/Book Ratio2.56
Enterprise/Revenue2.52
Enterprise/EBITDA15.95

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.06
Operating Margin0.27

Management Effectiveness

Return On Assets0.04
Return On Equity0.08

Income Statement

Revenue72.35B
Revenue/Share480.92
Gross Profit46.99B
EBITDA10.48B
Net Income8.39B
Diluted EPS52.85

Balance Sheet

Total Cash6.23B
Total Cash/Share39.34
Total Debt28.83B
Total Debt/Equity0.44
Current Ratio1.66
Book Value Per Share414.89

Price History

52-Week Change10.9
52-Week High1,248
52-Week Low802
Moving Average 50 Days1,089.07
Moving Average 200 Days1,079.89

Statistics

Average Volume154,961
Shares Outstanding158.5M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate5
Trailing Annual Dividend Yield0.47
Payout Ratio0
Last Split Factor21:20
Last Split DateNovember 25, 2010